Single-chromosome Gains Commonly Function as Tumor Suppressors.

Area of Science:

• Genetics
• Cancer Biology
• Cell Biology

Background:

• Aneuploidy is a common characteristic of cancer cells.
• The precise role of aneuploidy in cancer development remains incompletely understood.
• Understanding aneuploidy's impact is crucial for cancer research.

Purpose of the Study:

• To investigate the functional consequences of aneuploidy on cancer development.
• To explore the relationship between single extra chromosomes and tumor formation.
• To elucidate the mechanisms by which aneuploidy influences cancer cell fitness and evolution.

Main Methods:

• Engineering cell lines to harbor single extra chromosomes (trisomy).
• Assessing the in vitro and in vivo growth of trisomic versus euploid cells.
• Evaluating the impact of oncogenic pathway activation on trisomic cell fitness.
• Analyzing chromosomal alterations in long-term cultured trisomic cells.

Main Results:

• Trisomic cell lines exhibited significantly poorer growth in vitro and as xenografts compared to euploid cells.
• Activation of oncogenic pathways did not rescue the fitness defect caused by aneuploidy.
• Prolonged growth led to the acquisition of additional chromosomal alterations in trisomic cells.
• These secondary alterations correlated with improved cell fitness, suggesting adaptation.

Conclusions:

• Single-chromosome gains can initially suppress tumor transformation.
• Aneuploidy's genome-destabilizing effects promote evolutionary flexibility in cancer cells.
• This adaptability may contribute to the aggressive phenotype of advanced cancers with complex karyotypes.
• Aneuploidy's dual role in suppressing initial growth while facilitating later adaptation is key to cancer progression.